Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00585455 · ClinicalTrials.gov registry record

Vascular Effects of Sertraline in Heart Failure

A clinical trial, sponsored by Yale University.

Terminated
Registry status
4
Enrollment target

NCT00585455 is a clinical trial that was terminated before completion, run by Yale University. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00585455 was terminated before completion, sponsored by Yale University.

TERMINATED
Registry status
4 participants
Enrollment target

Study Summary

To determine the effects of chronic sertraline treatment on brachial artery flow-mediated dilation in patients with chronic heart failure and depression

Interventions

  • DRUG sertraline

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2006-01
Est. Completion 2009-07

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT00585455

The ClinicalTrials.gov registry entry for NCT00585455 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which sertraline is the first listed.

NCT00585455 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00585455 about?

NCT00585455 is a clinical study titled "Vascular Effects of Sertraline in Heart Failure". To determine the effects of chronic sertraline treatment on brachial artery flow-mediated dilation in patients with chronic heart failure and depression

What is the current status of trial NCT00585455?

This trial is currently terminated. The enrollment target is 4 participants. The study started on 2006-01. Estimated completion is 2009-07.

What interventions are being tested in trial NCT00585455?

The interventions under investigation include: sertraline (DRUG).

Who is sponsoring clinical trial NCT00585455?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.